The effects of ziprasidone on steady-state lithium levels and renal clearance of lithium

British Journal of Clinical Pharmacology

Volumn 49, Issue SUPPL. 1, 2000, Pages 61-64

  Apseloff, G ^a   Mullet, D ^a   Wilner, K D ^b   Anziano, R J ^b   Tensfeldt, T G ^b   Pelletier, S M ^b   Gerber, N ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Lithium; Pharmacokinetics; Renal clearance; Ziprasidone

Indexed keywords

LITHIUM; LITHIUM CARBONATE; ZIPRASIDONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; LITHIUM BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034098207     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00155.x     Document Type: Article

References (20)

1. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In The Pharmacological Basis of Therapeutics, Ninth Edition. eds, Gilman AG, Molinoff PB, Ruddon RW, Hardman JG, Limbird LE. New York: McGraw-Hill, 1995; 431-459.
2. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet 1995; 29: 172-191.
3. Siris SG. Pharmacological treatment of depression in schizophrenia. In Depression in Schizophrenia, ed. Delisi LE, Washington, DC: American Psychiatric Press, 1990; 141-162.
4. Keck PE Jr, McElroy SL, Strakowski SM, et al. Pharmacologic treatment of schizoaffective disorder. Psychopharmacol Berl 1994; 114: 529-538.
5. Kimmmel S, Calabrese JR, Woyshville MJ, et al. Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994; 55(Suppl B): 91-93.
6. Madhusoodanan S, Brenner R, Araujo L, et al. Efficacy of risperidone for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series. J Clin Psychiatry 1994; 56: 514-518.
7. Azorin JM. Long-term treatment of mood disorders in schizophrenia. Acta Psychiatr Scand 1995; 388(Suppl): 20-23.
8. Marcus WL. Lithium: a review of its pharmacokinetics, health effects and toxicology. J Environ Pathol Toxicol Oncol 1994; 13: 73-79.
9. Ragheb M, Ban TA, Buchanan D, Frolich JC. Interaction of indomethacin and ibuprofen with lithium in manic patients under a steady state lithium level. J Clin Psychiatry 1980; 41: 397-398.
10. McGennis AJ. Lithium carbonate and tetracycline interaction. Br Med J 1978; 1: 1183.
11. Amdisen A. Lithium and drug interactions. Drugs 1982; 24: 133-139.
12. Jefferson JW, Greist JH. Lithium and the kidney. In Psychopharmacology Update: New and Neglected Areas, eds, Davis JM, Greenblatt D. New York: Grune and Stratton, 1979; 81-104.
13. Meyer MC, Baldessarini RJ, Goff DC, Centorrino F. Clinical significant interactions of psychotropic agents with antipsychotic drugs. Drug Safety 1996; 15: 333-346.
14. Harvey NS, Merriman S. Review of clinically important drug interactions with lithium. Drug Safety 1994; 10: 455-463.
15. Hadley A, Cason MP. Mania resulting from lithium-fluoxetine combination. Am J Psychiatry 1989; 145: 1637-1638.
16. Evans M, Marwick P. Fluvoxamine and lithium: an unusual interaction. Br J Psychiatry 1990; 156: 286.
17. Loudon JB, Waring H. Toxic reactions to lithium and haloperidol. Lancet 1976; ii: 1088.
18. Baastrup PC, Hollnagel P, Sorensen R, Schon H. Adverse reactions in treatment with lithium carbonate and haloperidol. JAMA 1976; 236: 2645-2646.
19. Hansen JL. The measurement of serum and lithium by atomic absorption spectrometry. Am J Med Tech 1968; 34: 1-9.
20. Janiszewski JS, Fouda HG, Cole RO. Development and validation of a high-sensitivity assay for an antipsychotic agent, CP-88,059, with solid-phase extraction and narrow-bore high-performance liquid chromatography. J Chromatogr 1995; 668: 133-139.